PubMed=6154311; DOI=10.1360/ya1980-23-2-236
Chen R.-M., Zhu D.-H., Ye X.-Z., Shen D.-W., Lu R.-H.
Establishment of three human liver carcinoma cell lines and some of their biological characteristics in vitro.
Sci. Sin. 23:236-247(1980)
PubMed=6275024; DOI=10.1099/0022-1317-57-1-95
Koshy R., Maupas P., Muller R., Hofschneider P.H.
Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues.
J. Gen. Virol. 57:95-102(1981)
DOI=10.1007/978-4-431-68349-0_4
Alexander J.J.
Human hepatoma cell lines.
(In) Neoplasms of the liver; Okuda K., Ishak K.G. (eds.); pp.47-56; Springer; Tokyo (1987)
PubMed=11774261; DOI=10.1002/ijc.1597
Zhang R., Wang X., Guo L., Xie H.
Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase.
Int. J. Cancer 97:173-179(2002)
PubMed=23505090; DOI=10.1002/hep.26402
Wang K., Lim H.Y., Shi S., Lee J., Deng S., Xie T., Zhu Z., Wang Y., Pocalyko D., Yang W.J., Rejto P.A., Mao M., Park C.-K., Xu J.
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Hepatology 58:706-717(2013)
PubMed=28807831; DOI=10.1016/j.jhep.2017.08.002
Rebouissou S., Zucman-Rossi J., Moreau R., Qiu Z.-X., Hui L.-J.
Note of caution: contaminations of hepatocellular cell lines.
J. Hepatol. 67:896-897(2017)